By Professor David Simon Ziegler

Journal articles

Burke MJ; Kostadinov R; Sposto R; Gore L; Kelley SM; Rabik C; Trepel JB; Lee MJ; Yuno A; Lee S; Bhojwani D; Jeha S; Chang BH; Sulis ML; Hermiston ML; Gaynon P; Huynh V; Verma A; Gardner R; Heym KM; Dennis RM; Ziegler DS; Laetsch TW; Oesterheld JE; Dubois SG; Pollard JA; Glade-Bender J; Cooper TM; Kaplan JA; Farooqi MS; Yoo B; Guest E; Wayne AS; Brown PA, 2020, 'Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study', Clinical Cancer Research, 26, pp. 2297 - 2307, http://dx.doi.org/10.1158/1078-0432.CCR-19-1251

Pagé MG; Kudrina I; Zomahoun HTV; Croteau J; Ziegler D; Ngangue P; Martin E; Fortier M; Boisvert EE; Beaulieu P; Charbonneau C; Cogan J; Daoust R; Martel MO; Néron A; Richebé P; Clarke H, 2020, 'A Systematic Review of the Relative Frequency and Risk Factors for Prolonged Opioid Prescription Following Surgery and Trauma Among Adults', Annals of Surgery, 271, pp. 845 - 854, http://dx.doi.org/10.1097/SLA.0000000000003403

Ghabrash MF; Bahremand A; Veilleux M; Blais-Normandin G; Chicoine G; Sutra-Cole C; Kaur N; Ziegler D; Dubreucq S; Juteau LC; Lestage L; Jutras-Aswad D, 2020, 'Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review', Journal of Dual Diagnosis, 16, pp. 191 - 207, http://dx.doi.org/10.1080/15504263.2020.1726549

Magro E; Darsaut TE; Mezui EDO; Bojanowski MW; Ziegler D; Gentric JC; Roy D; Raymond J, 2020, 'Arteriovenous malformations of the posterior fossa: a systematic review', Acta Neurochirurgica, 162, pp. 905 - 910, http://dx.doi.org/10.1007/s00701-020-04260-6

Vetsch J; Hetherington K; Wakefield C; Ziegler D, 2020, 'Families’ experiences of a precision medicine trial for childhood cancer', Oncology Central

Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A, 2020, 'Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study', Acta Neuropathologica, 139, pp. 223 - 241, http://dx.doi.org/10.1007/s00401-019-02111-y

Gedye C; Sachchithananthan M; Leonard R; Jeffree RL; Buckland ME; Ziegler DS; Graeber MB; Day BW; McDonald KL; Lasocki A; Back M; Besser M; Boyd A; Byrne J; Cher L; Cook R; Day J; Davidson A; Devereux L; Dexter M; Donnelly R; Drummond K; Eckstein L; Gan H; Garrick T; Gottardo N; Harper C; Johns T; Khasraw M; Kichenadasse G; Eng-Siew K; Lipworth W; Ludlow L; Moore A; Munoz L; Nahar N; Olson S; Ormsby R; Parkinson J; Partanen A; Raymond E; Reddel R; Robbins P; Rosenthal M; Saunus J; Shivalingam B; Simes J; Stringer B; Thorne H; Vajdic C; Varikatt W; Walker D; Wheeler H; White D; Yip S; Nowak AK, 2020, 'Driving innovation through collaboration: Development of clinical annotation datasets for brain cancer biobanking', Neuro-Oncology Practice, 7, pp. 31 - 37, http://dx.doi.org/10.1093/nop/npz036

Shen H; Yu M; Tsoli M; Chang C; Joshi S; Liu J; Ryall S; Chornenkyy Y; Siddaway R; Hawkins C; Ziegler DS, 2020, 'Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas', Neuro-Oncology, 22, pp. 139 - 151, http://dx.doi.org/10.1093/neuonc/noz140

McGill BC; Wakefield CE; Hetherington K; Munro LJ; Warby M; Lau L; Tyrrell V; Ziegler DS; O’brien TA; Marshall GM; Malkin D; Hansford JR; Tucker KM; Vetsch J; O'Brien T, 2020, '“Balancing Expectations with Actual Realities”: Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial', Journal of Personalized Medicine, 10, pp. 9, http://dx.doi.org/10.3390/jpm10010009

Hanson D; Hoffman LM; Nagabushan S; Goumnerova LC; Rathmann A; Vogel T; Ziegler DS; Chi S, 2020, 'A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes', Neuro-Oncology Advances, 2, http://dx.doi.org/10.1093/noajnl/vdaa120

Burke MJ; Ziegler DS; Bautista Sirvent FJ; Attarbaschi A; Gore L; Locatelli F; O'Brien MM; Pauly M; Obreja M; Morris CL; Baruchel A, 2019, 'Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)', Blood, 134, pp. 3873 - 3873, http://dx.doi.org/10.1182/blood-2019-127350

Li B; Vasiljevic A; Dufour C; Ho B; Hwang E; Gururangan S; Hansford J; Laquerriere A; Delisle M-B; Fangusaro J; Forest F; Sumihito N; Toledano H; Birks D; Fan X; Fouladi M; Gajjar A; Gauchotte G; Hoffman L; Jones C; Loussouarn D; Mokhtari K; Pomeroy S; Rousseau A; Somers G; Taylor M; Ziegler DS; Lu M; Hawkins C; Grundy R; Jouvet A; Bouffet E; Ashley Hill D; Huang A, 2019, 'PDTM-24. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM', Neuro-Oncology, 21, pp. vi192 - vi192, http://dx.doi.org/10.1093/neuonc/noz175.800

Doz F; Geoerger B; DuBois SG; Grilley-Olson JE; van Tilburg CM; Italiano A; Lissat A; Jin Kang H; Tahara M; Boni V; Perreault S; Capra M; Nanda S; Brega N; Holynskyj A; Ziegler DS; Hong DS; Hyman DM; Drilon A, 2019, 'RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS', Neuro-Oncology, 21, pp. vi231 - vi231, http://dx.doi.org/10.1093/neuonc/noz175.968

Robertson EG; Wakefield CE; Cohn RJ; Battisti RA; Donoghoe MW; Ziegler DS; Fardell JE; Mitchell R; O'Brien TA, 2019, 'Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer', Psycho-Oncology, 28, pp. 1520 - 1529, http://dx.doi.org/10.1002/pon.5109

Franshaw L; Tsoli M; Lau LMS; Ziegler DS, 2019, 'Translating palbociclib to the clinic for DIPG - What is truly achievable?', EBioMedicine, 45, pp. 22, http://dx.doi.org/10.1016/j.ebiom.2019.06.024

Vetsch J; Wakefield CE; Techakesari P; Warby M; Ziegler DS; O'Brien TA; Drinkwater C; Neeman N; Tucker K, 2019, 'Healthcare professionals’ attitudes toward cancer precision medicine: A systematic review', Seminars in Oncology, 46, pp. 291 - 303, http://dx.doi.org/10.1053/j.seminoncol.2019.05.001

DuBois SG; Albert CM; Mascarenhas L; Laetsch TW; van Tilburg CM; Potter SL; Turpin B; Glade Bender JL; Spunt SL; Hladun R; Casanova M; Ziegler DS; Morgenstern DA; Eary T; Ibabekci S; Qamoos H; Rothenberg SM; Cox MC; Balis FM; Pappo AS, 2019, 'A phase I study of LOXO-292, a highly selective RET inhibitor, in pediatric patients with RET-altered cancers.', Journal of Clinical Oncology, 37, pp. TPS10066 - TPS10066, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps10066

Drilon AE; DuBois SG; Farago AF; Geoerger B; Grilley-Olson JE; Hong DS; Sohal D; van Tilburg CM; Ziegler DS; Ku N; Cox MC; Nanda S; Childs BH; Doz FP, 2019, 'Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.', Journal of Clinical Oncology, 37, pp. 2006 - 2006, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2006

Hanson D; Chi S; Ziegler D, 2019, 'MEDU-38. A CASE SERIES OF CHILDREN WITH EMBRYONAL TUMOR WITH MULTILAYER ROSETTES TREATED WITH A MODIFIED IRS-III CHEMOTHERAPY BACKBONE', Neuro-Oncology, 21, pp. ii111 - ii111, http://dx.doi.org/10.1093/neuonc/noz036.196

Rampersaud E; Ziegler DS; Iacobucci I; Payne-Turner D; Churchman ML; Schrader KA; Joseph V; Offit K; Tucker K; Sutton R; Warby M; Chenevix-Trench G; Huntsman DG; Tsoli M; Scott Mead R; Qu C; Leventaki V; Wu G; Mullighan CG, 2019, 'Germline deletion of ETV6 in familial acute lymphoblastic leukemia', Blood Advances, 3, pp. 1039 - 1046, http://dx.doi.org/10.1182/bloodadvances.2018030635

Fultang L; Gamble LD; Gneo L; Berry AM; Egan SA; De Bie F; Yogev O; Eden GL; Booth S; Brownhill S; Vardon A; McConville CM; Cheng PN; Norris MD; Etchevers HC; Murray J; Ziegler DS; Chesler L; Schmidt R; Burchill SA; Haber M; De Santo C; Mussai F, 2019, 'Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma', Cancer Research, 79, pp. 611 - 624, http://dx.doi.org/10.1158/0008-5472.CAN-18-2139

Tsoli M; Shen H; Mayoh C; Franshaw L; Ehteda A; Upton D; Carvalho D; Vinci M; Meel MH; van Vuurden D; Plessier A; Castel D; Drissi R; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Francis S; Ludlow LEA; Carai A; Mastronuzzi A; Liu B; Hansford J; Gottardo NG; Hassall T; Kirby M; Fouladi M; Hawkins C; Monje M; Grill J; Jones C; Hulleman E; Ziegler DS, 2019, 'Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma (Journal of Neuro-Oncology, (2019), 141, 2, (253-263), 10.1007/s11060-018-03038-2)', Journal of Neuro-Oncology, 141, pp. 265, http://dx.doi.org/10.1007/s11060-018-03060-4

Gamble LD; Purgato S; Murray J; Xiao L; Yu DMT; Hanssen KM; Giorgi FM; Carter DR; Gifford AJ; Valli E; Milazzo G; Kamili A; Mayoh C; Liu B; Eden G; Sarraf S; Allan S; Giacomo SD; Flemming CL; Russell AJ; Cheung BB; Oberthuer A; London WB; Fischer M; Trahair TN; Fletcher JI; Marshall GM; Ziegler DS; Hogarty MD; Burns MR; Perini G; Norris MD; Haber M, 2019, 'Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma', Science Translational Medicine, 11, http://dx.doi.org/10.1126/scitranslmed.aau1099

Tsoli M; Shen H; Mayoh C; Franshaw L; Ehteda A; Upton D; Carvalho D; Vinci M; Meel MH; van Vuurden D; Plessier A; Castel D; Drissi R; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Francis S; Ludlow LEA; Carai A; Mastronuzzi A; Liu B; Hansford J; Gottardo N; Hassall T; Kirby M; Fouladi M; Hawkins C; Monje M; Grill J; Jones C; Hulleman E; Ziegler DS, 2019, 'International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma', Journal of Neuro-Oncology, 141, pp. 253 - 263, http://dx.doi.org/10.1007/s11060-018-03038-2

Vetsch J; Wakefield CE; Duve E; McGill BC; Warby M; Tucker KM; Malkin D; Lau L; Ziegler DS, 2019, 'Parents', health care professionals', and scientists' experiences of a precision medicine pilot trial for patients with high-risk childhood cancer: A qualitative study', JCO Precision Oncology, 3, pp. 1 - 11, http://dx.doi.org/10.1200/PO.19.00235

Franshaw L; Tsoli M; Byrne J; Mayoh C; Sivarajasingam S; Norris M; Marshall GM; Ziegler DS, 2019, 'Predictors of Success of Phase II Pediatric Oncology Clinical Trials', Oncologist, 24, pp. e765 - e774, http://dx.doi.org/10.1634/theoncologist.2017-0666

Ziegler DS; Doz F; Geoerger B; Dubois S; Grilley-Olson JE; van Tilburg C; Italiano A; Lissat A; Kang J-H; Tahara M; Boni V; Perreault S; Capra M; Nanda S; Brega N; Holynskyj A; Hong DS; Hyman D; Drilon A, 2019, 'Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours', Annals of Oncology, 30, pp. ix124 - ix124, http://dx.doi.org/10.1093/annonc/mdz431.003

Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS; Arndt G, 2018, 'Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer', Cancer Biology and Therapy, 19, pp. 1078 - 1087, http://dx.doi.org/10.1080/15384047.2018.1491498

Dixon F; Ziegler DS; Bajuk B; Wright I; Hilder L; Abdel Latif ME; Somanathan A; Oei JL, 2018, 'Treatment with nitric oxide in the neonatal intensive care unit is associated with increased risk of childhood cancer', Acta Paediatrica, International Journal of Paediatrics, 107, pp. 2092 - 2098, http://dx.doi.org/10.1111/apa.14436

Kabalan P; Gifford AJ; Ziegler DS, 2018, 'Unresectable VIP-secreting neuroblastoma: Efficacy of debulking and steroids for symptom control', Pediatric Blood and Cancer, 65, http://dx.doi.org/10.1002/pbc.27358

Sun W; Malvar J; Sposto R; Verma A; Wilkes JJ; Dennis R; Heym K; Laetsch TW; Widener M; Rheingold SR; Oesterheld J; Hijiya N; Sulis ML; Huynh V; Place AE; Bittencourt H; Hutchinson R; Messinger Y; Chang B; Matloub Y; Ziegler DS; Gardner R; Cooper T; Ceppi F; Hermiston M; Dalla-Pozza L; Schultz KR; Gaynon P; Wayne AS; Whitlock JA, 2018, 'Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study', Leukemia, 32, pp. 2316 - 2325, http://dx.doi.org/10.1038/s41375-018-0094-0

Vedi A; Mitchell R; Shanmuganathan S; Oswald C; Marshall GM; Trahair T; Sivarajasingam S; Ziegler DS, 2018, 'Increased Survival for Children with Acute Myeloid Leukemia Results from Improved Postrelapse Treatment', Journal of Pediatric Hematology/Oncology, 40, pp. 541 - 547, http://dx.doi.org/10.1097/MPH.0000000000001215

Allanson BM; Weber MA; Jackett LA; Chan C; Lau L; Ziegler DS; Warby M; Mayoh C; Cowley MJ; Tucker KM; Long GV; Maher A; Anazodo A; Scolyer RA, 2018, 'Oral malignant gastrointestinal neuroectodermal tumour with junctional component mimicking mucosal melanoma', Pathology, 50, pp. 648 - 653, http://dx.doi.org/10.1016/j.pathol.2018.07.002

Ziegler DS; Wong M; Mayoh C; Kumar A; Tsoli M; Mould E; Tyrrell V; Khuong-Quang DA; Pinese M; Gayevskiy V; Cohn RJ; Lau LMS; Reynolds M; Cox MC; Gifford A; Rodriguez M; Cowley MJ; Ekert PG; Marshall GM; Haber M; Wong-Erasmus M, 2018, 'Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma', British Journal of Cancer, 119, pp. 693 - 696, http://dx.doi.org/10.1038/s41416-018-0251-2

Allanson BM; Weber MA; Jackett LA; Chan C; Lau L; Ziegler D; Warby M; Mayoh C; Cowley MJ; Tucker KM; Long GV; Maher A; Anazodo A; Scolyer RA, 2018, 'Oral malignant gastrointestinal neuroectodermal tumour with junctional component mimicking mucosal melanoma.', Pathology, 50, pp. 648 - 653, http://dx.doi.org/10.1016/j.pathol.2018.07.002

Pagé MG; Kudrina I; Zomahoun HTV; Ziegler D; Beaulieu P; Charbonneau C; Cogan J; Daoust R; Martel MO; Néron A; Richebé P; Clarke H, 2018, 'Relative frequency and risk factors for long-term opioid therapy following surgery and trauma among adults: A systematic review protocol', Systematic Reviews, 7, http://dx.doi.org/10.1186/s13643-018-0760-3

Hoffman LM; Van Zanten SEMV; Colditz N; Baugh J; Chaney B; Hoffmann M; Lane A; Fuller C; Miles L; Hawkins C; Bartels U; Bouffet E; Goldman S; Leary S; Foreman NK; Packer R; Warren KE; Broniscer A; Kieran MW; Minturn J; Comito M; Broxson E; Shih CS; Khatua S; Chintagumpala M; Carret AS; Escorza NY; Hassall T; Ziegler DS; Gottardo N; Dholaria H; Doughman R; Benesch M; Drissi R; Nazarian J; Jabado N; Boddaert N; Varlet P; Giraud G; Castel D; Puget S; Jones C; Hulleman E; Modena P; Giagnacovo M; Antonelli M; Pietsch T; Gielen GH; Jones DTW; Sturm D; Pfister SM; Gerber NU; Grotzer MA; Pfaff E; Von Bueren AO; Hargrave D; Solanki GA; Cvrlje FJ; Kaspers GJL; Vandertop WP; Grill J; Bailey S; Biassoni V; Massimino M; Calmon R; Sanchez E; Bison B; Warmuth-Metz M; Leach J; Jones B; Van Vuurden DG; Kramm CM; Fouladi M, 2018, 'Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries', Journal of Clinical Oncology, 36, pp. 1963 - 1972, http://dx.doi.org/10.1200/JCO.2017.75.9308

Gyawali P; Ziegler D; Cailhier JF; Denault A; Cloutier G, 2018, 'Quantitative Measurement of Erythrocyte Aggregation as a Systemic Inflammatory Marker by Ultrasound Imaging: A Systematic Review', Ultrasound in Medicine and Biology, 44, pp. 1303 - 1317, http://dx.doi.org/10.1016/j.ultrasmedbio.2018.02.020

Erker C; Lane A; Chaney B; Escorza NY; Fuller C; Saab R; Kieran M; Packer R; Nazarian J; Minturn J; Dodgshun A; Parkin S; Foreman N; Broxson E; Lombardi MG; Goldman S; Sandler E; Warren K; Greiner R; Gottardo N; Dholaria H; Shih C-S; Hassall T; Hansford JR; Wang SS; Samson Y; Leary S; Ma J; Bartels U; Broniscer A; Monje M; Fisher P; Ziegler D; Wagner L; Koschmann C; Doughman R; Drissi R; Jones B; Leach J; White P; Dexheimer P; Hendershot J; Hawkins C; Bandopadhayay P; Fouladi M, 2018, 'DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY', Neuro-Oncology, 20, pp. i63 - i63, http://dx.doi.org/10.1093/neuonc/noy059.162

Bartlett A; Cochrane A; Lane A; Yanez-Escorza N; Chaney B; Doughman R; DeWire-Schottmiller M; Goldman S; Warren K; Bandopadhayay P; Foreman N; Shih C-S; Minturn J; Bartels U; Packer R; Nazarian J; Hassall T; Samson Y; Monje-Deisseroth M; Fisher P; Wagner L; Koschmann C; Ziegler D; Kieran M; Hawkins C; White P; Dexheimer P; Hendershot J; Drissi R; Fuller C; Leach J; Jones B; Fouladi M, 2018, 'DIPG-70. CLINICAL, RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN <3 YEARS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY', Neuro-Oncology, 20, pp. i63 - i63, http://dx.doi.org/10.1093/neuonc/noy059.163

Michaiel G; Strother D; Gottardo N; Bartels U; Coltin H; Eisenstat DD; Hukin J; Johnston DL; Wilson B; Zelcer S; Hansford JR; Wells O; AbdelBaki MS; Abu-Arja MH; Cole KA; Dhall G; Fisher PG; Hoffman L; Leary SES; Pickle EEO; Smiley NP; Smith A; Vinitsky A; Vitanza NA; Wright A; Yeo KK; Chow LML; Kirby M; Valvi S; Vanan MI; Wong G; Ziegler D; Bouffet E; Lafay-Cousin L, 2018, 'GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY', Neuro-Oncology, 20, pp. i88 - i88, http://dx.doi.org/10.1093/neuonc/noy059.270

Dodgshun A; Fukuoka K; Campbell B; Edwards M; Sexton-Oates A; Larouche V; Magimairajan V; Lindhorst S; Oren M; Mason G; Crooks B; Constantini S; Massimino M; Chiaravalli S; Ramdas J; Mason W; Shamvil A; Farah R; van Damme A; Opocher E; Hamid SA; Ziegler D; Samuel D; Cole KA; Tomboc P; Stearns D; Thomas G; Lossos A; Saffery R; Sullivan M; Hansford JR; Jones D; Tabori U, 2018, 'HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES', Neuro-Oncology, 20, pp. i92 - i93, http://dx.doi.org/10.1093/neuonc/noy059.292

Fletcher JI; Ziegler DS; Trahair TN; Marshall GM; Haber M; Norris MD, 2018, 'Too many targets, not enough patients: Rethinking neuroblastoma clinical trials', Nature Reviews Cancer, 18, pp. 389 - 400, http://dx.doi.org/10.1038/s41568-018-0003-x

Li BK; Vasiljevic A; Ho B; Jouvet A; Hwang EI; Hansford JR; Laquerriere A; Delisle M-B; Gururangan S; Fangusaro JR; Forest F; Sumihito N; Toledano H; Fouladi M; Gauchotte G; Ziegler DS; Bouffet E; Grundy RG; Dufour C; Huang AA, 2018, 'Genomic landscape of pineoblastoma.', Journal of Clinical Oncology, 36, pp. 2028 - 2028, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.2028

Marachelian A; Hogarty MD; Flynn A; Liu K; Gerner EW; Bruckheimer E; Shamirian A; Hasenauer C; Norris M; Haber M; Groshen SG; Ziegler DS; Matthay KK, 2018, 'NANT 2012-01: Phase 1 study of DFMO and celecoxib with cyclophosphamide and topotecan for relapsed or refractory high-risk neuroblastoma.', JOURNAL OF CLINICAL ONCOLOGY, 36, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10558

Sagnella SM; Trieu J; Brahmbhatt H; MacDiarmid JA; MacMillan A; Whan RM; Fife CM; McCarroll JA; Gifford AJ; Ziegler DS; Kavallaris M, 2018, 'Targeted doxorubicin-loaded bacterially derived nano-cells for the treatment of neuroblastoma', Molecular Cancer Therapeutics, 17, pp. 1012 - 1023, http://dx.doi.org/10.1158/1535-7163.MCT-17-0738

Robertson EG; Wakefield CE; Cohn RJ; O'Brien T; Ziegler DS; Fardell JE, 2018, 'The development of delta: Using agile to develop a decision aid for pediatric oncology clinical trial enrollment', JMIR Research Protocols, 7, pp. e119, http://dx.doi.org/10.2196/resprot.9258

Tsoli M; Liu J; Franshaw L; Shen H; Cheng C; Jung MS; Joshi S; Ehteda A; Khan A; Montero-Carcabosso A; Dilda PJ; Hogg P; Ziegler DS, 2018, 'Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma', Oncotarget, 9, pp. 7541 - 7556, http://dx.doi.org/10.18632/oncotarget.24045

Campbell BB; Light N; Fabrizio D; Zatzman M; Fuligni F; de Borja R; Davidson S; Edwards M; Elvin JA; Hodel KP; Zahurancik WJ; Suo Z; Lipman T; Wimmer K; Kratz CP; Bowers DC; Laetsch TW; Dunn GP; Johanns TM; Grimmer MR; Smirnov IV; Larouche V; Samuel D; Bronsema A; Osborn M; Stearns D; Raman P; Cole KA; Storm PB; Yalon M; Opocher E; Mason G; Thomas GA; Sabel M; George B; Ziegler DS; Lindhorst S; Issai VM; Constantini S; Toledano H; Elhasid R; Farah R; Dvir R; Dirks P; Huang A; Galati MA; Chung J; Ramaswamy V; Irwin MS; Aronson M; Durno C; Taylor MD; Rechavi G; Maris JM; Bouffet E; Hawkins C; Costello JF; Meyn MS; Pursell ZF; Malkin D; Tabori U; Shlien A, 2017, 'Comprehensive Analysis of Hypermutation in Human Cancer', Cell, 171, pp. 1042 - 1056.e10, http://dx.doi.org/10.1016/j.cell.2017.09.048

Campbell BB; Angelini P; Light N; Bouffet E; Larouche V; Samuel D; Stearns D; Cole KA; Opocher E; Sabel M; George B; Ziegler D; Laperriere N; Meyn S; Malkin D; Shlien A; Tabori U, 2017, 'PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION', Neuro-Oncology, 19, pp. vi194 - vi194, http://dx.doi.org/10.1093/neuonc/nox168.785

Back to profile page